USD 36.76
Price
-0.25
(-0.68%)
Day Change
|
|
---|
GSK, the overall quality is ok (Quality = 62) and the timing to buy is ...(Sign In to See)...
- Signal
- NEUTRAL
- Signal Description
- Company financial health is OK
- Reason
-
Acceleration of ROE growth rate is below our criteria.
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Acceleration of net profit margin growth rate is below our criteria
In details, quality factors are not quite good , financial health is not good , and ability to make profit is ok , ...
Quality Factors |
|
54% |
Timing Factors |
|
28% |
Financial Health |
|
43% |
Ability to Make Profit |
|
68% |
Return to Investors |
|
62% |
Registration Details |
Analyze Date | 2024-10-31 20:16:40 |
Symbol | GSK |
Name | GLAXOSMITHKLINE PLC ADR |
Sector | Healthcare >> Drug Manufacturers - General |
Market | NYSE |
Listed Shares | 2,039.49 M |
Par Value | N/A |
Calculated From | Quarter |
Sign | N/A |
Market Cap (M.USD) / Sector Average | 77,847.33 / 229,809.10 |
News, Concensus, ... |
Estimation Consensus | See at WSJ.com |
Full details | See at WSJ.com |
Chart | See in Chart feature |
News | See at Yahoo Finance |